DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Fluticasone furoate; umeclidinium bromide; vilanterol trifenatateis the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. There are nineteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Fluticasone furoate; umeclidinium bromide; vilanterol trifenatate has five hundred and three patent family members in fifty-two countries.
There are twenty-nine drug master file entries for fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. One supplier is listed for this compound.
Summary for fluticasone furoate; umeclidinium bromide; vilanterol trifenatate
|Drug Master File Entries:||29|
|Suppliers / Packagers:||1|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for fluticasone furoate; umeclidinium bromide; vilanterol trifenatate|
|DailyMed Link:||fluticasone furoate; umeclidinium bromide; vilanterol trifenatate at DailyMed|
Recent Clinical Trials for fluticasone furoate; umeclidinium bromide; vilanterol trifenatate
Identify potential brand extensions & 505(b)(2) entrants
|York Bioanalytical Solution||Phase 3|
|Q2 Solutions, LLC||Phase 3|
Pharmacology for fluticasone furoate; umeclidinium bromide; vilanterol trifenatate
|Drug Class||Corticosteroid |
|Mechanism of Action||Corticosteroid Hormone Receptor Agonists |
|Country||Patent Number||Estimated Expiration|
|Hong Kong||1066479||Start Trial|
|World Intellectual Property Organization (WIPO)||03066024||Start Trial|
|>Country||>Patent Number||>Estimated Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|1305329||CA 2008 00022||Denmark||Start Trial|
|1740177||2014/057||Ireland||Start Trial||PRODUCT NAME: UMECLIDINIUM BROMIDE; REGISTRATION NO/DATE: EU/1/14/922/001-003 20140428|
|1740177||122014000096||Germany||Start Trial||PRODUCT NAME: UMECLIDINIUMBROMID; REGISTRATION NO/DATE: EU/1/14/922/001-003 20140428|
|1740177||58/2014||Austria||Start Trial||PRODUCT NAME: UMECLIDINIUMBROMID; REGISTRATION NO/DATE: EU/1/14/922 (MITTEILUNG) 20140430|
|1305329||08C0014||France||Start Trial||PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111|
|1740177||CR 2014 00052||Denmark||Start Trial||PRODUCT NAME: UMECLIDINIUMBROMID; REG. NO/DATE: EU/1/14/922/001-003 20140430|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.